1. Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
   Jolieke G van Oosterwijk et al, 2012, BMC Cancer CrossRef
2. Characterization of a New Human Cell Line (CH-3573) Derived from a Grade II Chondrosarcoma with Matrix Production
   Silvia Calabuig-Fariñas et al, 2012, Pathol. Oncol. Res. CrossRef
3. Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution
   Ruoyu Miao et al, 2019, Sarcoma CrossRef
4. Clonality analysis and IDH1 and IDH2 mutation detection in both components of dedifferentiated chondrosarcoma, implicated its monoclonal origin
   Tingting Yang et al, 2020, Journal of Bone Oncology CrossRef
5. Dedifferentiated Central Chondrosarcoma: A Clinical, Histopathological, and Immunohistochemical Analysis of 57 Cases
   Li-Hua Gong et al, 2021, Front. Med. CrossRef
6. The molecular pathogenesis of dedifferentiated chondrosarcoma
   Akio Sakamoto, 2014, IJOO CrossRef
7. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation
   Makoto Emori et al, 2023, Human Cell CrossRef
8. Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
   Weronika Zając et al, 2023, Cancers CrossRef